EMA Recommends Approval of Eli Lilly's Obesity Treatment Pill Foundayo
NVO Novo Nordisk ADR
$38.42 -1.06%
View chart & analysis → - 1The European Medicines Agency committee recommended approval for Eli Lilly's obesity treatment pill Foundayo.
- 2Eli Lilly's Foundayo sales reached $98 million in the second quarter.
- 3Novo Nordisk's Wegovy pill sales for the same quarter were 3.22 billion Danish krone.
So what's the key point?
A decision on the approval of Eli Lilly's obesity treatment pill is expected in Europe. This drug recorded sales of $98 million.
Source TIKR · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.